ADMA Biologics ADMA and Takeda TAK are leading players in the plasma derived immunoglobulin sector. ADMA markets ...

The U.S. Intravenous Immunoglobulin Market plays a crucial role in treating immunodeficiency diseases and various autoimmune disorders, reflecting a steady evolution influenced by advanced therapies ...

The EC has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous injection to treat CIDP.

A patient with severe postural orthostatic tachycardia syndrome (POTS) and mast cell activation syndrome (MCAS) received immunotherapy with low-dose naltrexone (LDN) and intravenous immunoglobulin ...

Intravenous immunoglobulin therapy (IVIG) is a critical treatment modality in the management of a spectrum of immunodeficiencies, autoimmune disorders, and inflammatory conditions.

The IVIG-induced lipogenesis was driven by F(ab’) 2 fragments and required the presence of sialylated glycans on immunoglobulin G (IgG). Investigators concluded that IVIG targeted immune cell ...

At Marshfield Children’s Hospital, Dr. Dolly Paw-ton, the facility dog, is helping make them happen. One Wausau family sees ...

Minor AEs are common with IVIG treatment and range from 2% to 25% per infusion. [24,25] The most commonly reported AE'-associated with Privigen® is headache, which occurs in 65% of patients.

IVIG is employed in treating MIS-C due to the clinical parallels between MIS-C and Kawasaki disease; IVIG is a well-established therapy for mitigating the risk of coronary artery aneurysms . However, ...

Similarly, kidney function declined more slowly in the IVIG group, with an average monthly drop in eGFR of just -0.4 ml/min, compared to -1.1 ml/min in the no-IVIG group. Although patient and graft ...